Microporous methacrylated glycol chitosan-montmorillonite nanocomposite hydrogel for bone tissue engineering. by Cui, Zhong-Kai et al.
UCLA
UCLA Previously Published Works
Title
Microporous methacrylated glycol chitosan-montmorillonite nanocomposite hydrogel for 
bone tissue engineering.
Permalink
https://escholarship.org/uc/item/3vm6v68f
Journal
Nature communications, 10(1)
ISSN
2041-1723
Authors
Cui, Zhong-Kai
Kim, Soyon
Baljon, Jessalyn J
et al.
Publication Date
2019-08-06
DOI
10.1038/s41467-019-11511-3
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
ARTICLE
Microporous methacrylated glycol chitosan-
montmorillonite nanocomposite hydrogel for bone
tissue engineering
Zhong-Kai Cui1,2,5, Soyon Kim 3,5, Jessalyn J. Baljon3, Benjamin M. Wu2,3, Tara Aghaloo4 & Min Lee 2,3
Injectable hydrogels can fill irregular defects and promote in situ tissue regrowth and
regeneration. The ability of directing stem cell differentiation in a three-dimensional micro-
environment for bone regeneration remains a challenge. In this study, we successfully
nanoengineer an interconnected microporous networked photocrosslinkable chitosan in situ-
forming hydrogel by introducing two-dimensional nanoclay particles with intercalation
chemistry. The presence of the nanosilicates increases the Young’s modulus and stalls the
degradation rate of the resulting hydrogels. We demonstrate that the reinforced hydrogels
promote the proliferation as well as the attachment and induced the differentiation of
encapsulated mesenchymal stem cells in vitro. Furthermore, we explore the effects of
nanoengineered hydrogels in vivo with the critical-sized mouse calvarial defect model. Our
results confirm that chitosan-montmorillonite hydrogels are able to recruit native cells and
promote calvarial healing without delivery of additional therapeutic agents or stem cells,
indicating their tissue engineering potential.
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T issue engineering exploits a combination of cells, engi-neering and materials methods, along with proper bio-chemical and physiochemical factors to improve or replace
biological tissues, including the skin, cartilage, bladder, blood
vessels, and bone1. The decisive contribution of the tissue engi-
neering matrix in ensuring the regeneration potential of stem and
progenitor cells has been emphasized increasingly2–4. Progress in
cell selection, cell culture, and new material formulations has led
to the development of more effective therapies for tissue engi-
neering and regenerative medicine (TERM). Various materials
have been explored for regenerative applications, including
naturally occurring products and synthetic materials5,6. Generally
speaking, the intrinsic properties of naturally derived materials,
such as collagens, are definitely attractive; however, the com-
plexities of purification, immunogenicity, mechanical properties,
and pathogen transmission significantly limit their application. In
light of this, greater control over material properties and tissue
responses has garnered more attention based on designable
modern material science.
Biomaterials are having great impact on the medical treatments
in helping to solve clinical problems. In the field of medicine,
drug-eluting stent coated with polymers and controlled drug
release systems constituted with biomaterials have been saving
hundreds of thousands of lives each year7,8. In the field of TERM,
the combination of biomaterial scaffold and certain cells is pos-
sible to replace biological tissues1. In the field of medical devices,
biomaterials are also playing a significantly important role as the
core components in surgical sutures, bioadhesives, and dental
implants9. Clays and clay minerals are emerging materials for
biomaterial design to provide new strategies for TERM. The usage
of inorganic layered nanomaterials for medical purpose dates
back to ancient time, such as for wound healing and hemorrhage
inhibition10. Nowadays, clays and clay minerals are being applied
in pharmaceuticals as active ingredients or excipients, and in
cosmetics as creams, powders, and emulsions10. The interactions
between clay nanoparticles and drugs as well as other biological
molecules have been well investigated and therefore exploited for
controlled delivery11,12, and moreover, the addition of clay into
polymers enhances the mechanical properties owing to the for-
mation of nanocomposites13,14.
Montmorillonite (MMT) is a major component of Bentonite,
which is already approved by the FDA as an additive in various
medicinal products11. Studies on the acute and chronic toxicities
of MMT have confirmed the absence of any negative effects,
even on embryos of pregnant Sprague–Dawley rats15,16. MMT
is a layered silicate [(Na,Ca)0.33(Al,Mg)2Si4O10(OH)2•nH2O],
belonging to the smectite group of minerals, with high
specific surface area (up to 600 m2 g−1) and aspect ratio. The
repeating structural unit of MMT consists of one alumina octa-
hedral sheet sandwiched in between two silicon tetrahedral layers.
The overall surface charge is light negative because of the dom-
ination of the oxide anions, which facilitates mixing with cationic
agents. The MMT particles are typically in a plate-shape, ren-
dering ~1 nm in thickness and 0.2–2 μm in diameter. The bio-
compatibility, availability, and feasibility of this particular mineral
has garnered significant attention in recent years. Extensive
research has been carried out to investigate for the purpose of
drug and gene delivery with natural or modified MMT11,17,18. In
addition, several reports have demonstrated that fabrication of
scaffolds by introduction of MMT in natural biomaterials,
including gelatin19,20, collagen21, silk22, and chitosan23,24,
improved cell-scaffold interactions, cell proliferation, and
enhanced cell differentiation. Although all those hard scaffolds
were reported with porous structure under high vacuum and dry
conditions, besides those experiments were limited only in vitro,
which are not ideal to be applied in TERM, as it is not possible to
include any live cells during fabrication of those scaffolds with
the conventional methods to create porous structure, such as
freeze-drying, porogen leaching. After the establishment of the
scaffolds, cells were loaded leading to nonuniform distribution.
Considering this, MMT is of interest for the formation of porous
structure, and to be investigated further in vivo for TERM as an
application.
Hydrogels derived from natural products are an appealing
three-dimensional biomaterial for tissue engineering. Compared
with hard scaffolds that require pre-shaping, soft hydrogels are
injectable and can fill any irregular shaped defects in a minimally
invasive manner. Recently, we have developed a photoinducible
hydrogel system of methacrylated glycol chitosan (MeGC) using
riboflavin as a photoinitiator25. MeGC hydrogels supported
proliferation and extracellular matrix deposition of encapsulated
mesenchymal stem cells25,26; however, the hydrogel itself showed
minimal bone-forming ability without osteogenic factors, bioac-
tive molecules, or encapsulated cells. One of the possible reasons
is lacking of porous structure in the MeGC hydrogel. Porosity is
reported to be necessary for new tissue formation as it allows the
cells to migrate, infiltrate, and proliferate in a 3D environment, as
well as for the vascularization, differentiation, and mass trans-
port27. Therefore, it is of interest to develop a hydrogel system
that could recruit native cells and facilitate bone formation with a
microporous interconnected structure.
In this study, we introduce MMT to the photopolymerizable
MeGC hydrogel system to fabricate an injectable highly osteo-
conductive in situ-forming biomaterial for bone regeneration. We
hypothesize that MMT can not only improve the microstructure
but also enhance the mechanical properties of cured MeGC
hydrogel. Therefore, we started with optimizing the proportion of
MMT in hydrogels and investigated the osteogenesis of encap-
sulated mesenchymal stem cells in vitro. We further evaluated the
ability of the nanocomposite hydrogels to recruit native cells and
improve bone formation in a critical-sized mouse calvarial defect
model. The treatment of bone defects remains one of the largest
challenges in musculoskeletal TERM, thereby our developed
nanosilicate-loaded MeGC hydrogel may represent a new mate-
rial design in the broadly interesting area of growth factor free
and cell-free strategies. This bioactive nanocomposite hydrogel
can provide an effective treatment for bone defects.
Results
Characterization of MeGC-MMT nanocomposite hydrogels.
Nanocomposite hydrogels including various amount of MMT
(0.5-4% w/v) were prepared as illustrated in Fig. 1a. We already
tested higher amount of MMT up to 10% in MeGC hydrogels. It
became too viscous to mix with poor handling, as the MMT ratio
increased over 4%. Therefore, we have selected the MMT ratio
between 0.5 and 4% for the investigation. The electrostatic
interactions between the heterogeneously distributed charges of
discotic MMT (overall negative charge) and MeGC hydrogel
matrices (positive charge) enhanced the Young’s modulus with an
increasing amount of MMT in the nanocomposite hydrogels from
10 kPa to over 60 kPa (Fig. 1b). Equilibrium water content (EWC)
inversely represents the cross-linking density and the mechanical
properties of a hydrogel28. Introduction of more than 0.5% MMT
in MeGC hydrogels significantly decreased the EWC of corre-
sponding nanocomposite hydrogels (Fig. 1c), indicating enhanced
mechanical properties. The dry weights of the MeGC-MMT
nanocomposite hydrogels were recorded for 42 days (Fig. 1d). As
observed in the degradation profiles, the degradation rate of the
1.5% and 3.0% MMT incorporated MeGC hydrogels was sig-
nificantly decreased compared with the control MeGC hydrogels
by ~40%. TGA degradation profiles confirmed the presence of
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MMT enhanced the thermal stability of MeGC hydrogels (Sup-
plementary Fig. 1).
The microstructure of MeGC and MeGC-MMT hydrogels
observed by SEM (Fig. 2) confirms the formation of a
microporous and interconnected network when MMT exceeds
1.5%, while a smooth continuous surface was acquired for the
control MeGC group, and a coarse continuous surface appeared
for 0.5 and 1% MMT groups. Porosity was quantified as an index
of surface area occupied by the pores in the SEM images. The
pore sizes were around 115 ± 40 μm for the 1.5% MMT group.
With the increasing MMT content, the pore sizes reached the
maximum of 150 ± 50 μm for the 3.0% MMT group. The
involvement of MMT thoroughly changed the microstructure of
MeGC hydrogels. In addition, MMT was well distributed in the
MeGC hydrogel matrices in all the nanocomposite groups
without aggregation, which was confirmed by EDS (Supplemen-
tary Table 1) and TEM observation (Supplementary Fig. 2).
Cytocompatibility of MeGC-MMT nanocomposite hydrogels.
Interconnected porous microstructure was created in the MeGC-
MMT nanocomposite hydrogels, the viability of cells inside which
was further investigated to optimize the composition of MMT for
bone tissue engineering. BMSCs were encapsulated inside of
various MeGC-MMT nanocomposite hydrogels and MeGC
hydrogels were employed as control. After 24-h culture, the cell
viability of the 1% and 1.5% MeGC-MMT groups was sig-
nificantly higher compared with the other groups (Fig. 3; Sup-
plementary Fig. 3). Considering the initial characterization of the
composite biomaterial, including the morphology, porosity, and
cell viability, we chose the 1.5 and 3% MMT groups for further
investigation. The hematoxyline and eosin (H&E) staining images
confirm the interconnected microporous structure in the 1.5 and
3% MMT groups, and the highest number of cells was observed in
the 1.5% MMT group, while MeGC hydrogel exhibited a smooth
surface (Fig. 4). In addition, round-shaped cells were observed in
the MeGC image, while spread cell morphology was seen in the
MMT containing nanocomposite hydrogels. Taken together, the
1.5% MeGC-MMT nanocomposite hydrogel group presented
the best support for cell proliferation.
Bioactivity of MeGC-MMT nanocomposite hydrogels. Differ-
entiation of BMSCs to osteoblasts typically can be evaluated by
the expression of early markers, such as ALP and the ultimate
calcium deposition29. The BMSCs encapsulated in the MeGC-
MMT (0%, 1.5 and 3%) were cultured for various duration. ALP
staining and ALP activity at day 3, 7 and alizarin red S staining
and its quantification at day 14, 28 were carried out (Fig. 5). The
1.5% MeGC-MMT group exhibited the most intensified staining
of ALP at both days 3 and 7 compared with the other two groups
(Fig. 5a), and ALP activity also showed the highest values for
1.5% MeGC-MMT group at both time points (Fig. 5b); while
comparable mineralization to the 3% MeGC-MMT group
(Fig. 5c).
qRT-PCR was employed to evaluate the differentiation of
BMSCs encapsulated in the MeGC-MMT nanocomposite hydro-
gels at a gene level. The gene expression of ALP, an early
osteogenic marker, and Runx2, one of the most specific
osteogenic differentiation markers in the earlier stage and OCN,
a late osteogenic marker, was examined at days 7 and 14,
respectively, and these results are presented in Fig. 6. Consistent
results confirmed that the 1.5% MeGC-MMT exhibited the most
powerful ability to promote the differentiation of BMSCs with a
MMT
MeGC
Riboflavin
Visible blue light
MeGC-MMT
MMT weight (%)
MMT weight (%) Time (Day)
Eq
ui
lib
riu
m
 w
a
te
r c
on
te
nt
 (%
)
G
el
 w
e
ig
ht
 (%
)
Yo
u
n
g’s
 m
o
du
lu
s 
(kP
a
)
70
60
50
40
30
20
10
100 120
100
80
60
40
20
0
0 7 14 21 28 35 42
98
96
94
92
90
0
0 0.5 1 1.5 2 3 4
0 0.5 1 1.5 2 3 4
a b
c d
Fig. 1 Characterization of photocross-linked MeGC-MMT nanocomposite hydrogels. a Schematic illustration of MeGC-MMT hydrogel cured by visible blue
light cross-linking with riboflavin as the photoinitiator in the presence of MMT. b Young’s modulus of MeGC-MMT nanocomposite hydrogels with various
amount of MMT. c Equilibrium water content of MeGC-MMT nanocomposite hydrogels. d Degradation profiles of MeGC-MMT nanocomposite hydrogels
in the presence of 0% (square), 1.5% (circle), and 3% (triangle) MMT in PBS at 37 °C for 42 days. Error bars indicate standard deviation (n= 5). *p < 0.05,
**p < 0.01, and ***p < 0.001 compared with the control MeGC group with 0% MMT (ANOVA followed by Tukey’s post hoc test)
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5.5-, 3.4-, and 4.5-fold increase of the gene expression of ALP,
Runx2, and OCN compared with the pure MeGC group. For the
3% MeGC-MMT group, statistically significant elevation of all
three gene expression was observed as well; however, compared
with the 1.5% MMT group, the ability of osteogenesis was
significantly limited.
In vivo bone regeneration of MeGC-MMT nanocomposites.
We took a further step to translate our 1.5% MeGC-MMT
nanocomposite hydrogel to the in vivo critical-sized calvarial
defect model of mice to evaluate bone regeneration. First, MeGC
and 1.5% MeGC-MMT hydrogels were injected in the defects,
and mice were euthanized 10 days post surgery to harvest the
tissue along with remaining hydrogels inside the defects. Sections
were stained with H&E in Fig. 7; overt native cell recruitment was
observed. There was highly improved cell infiltration with thick
granulation tissue formation composed of inflammatory cells and
collagen-producing fibroblasts in the defect treated with MeGC-
MMT nanocomposite hydrogel compared with the pure MeGC
hydrogel group, while poor cell infiltration was observed in the
blank control group.
As time progressed to week 6 post surgery, all mice were
euthanatized for tissue collection. Ex vivo high resolution μCT
was employed to evaluate the status of bone healing. The size of
the remaining defect treated with 1.5% MeGC-MMT nanocom-
posite hydrogel was remarkably smaller than that of the other two
groups, representative images are shown in Fig. 8a. The relative
new bone growth surface area, bone volume/tissue volume (BV/
TV %), and the trabecular number (Tb. N., mm−1) were extracted
from the μCT images. The normalization was based on the
original 3 mm defect area (Fig. 8b). The defects treated with
MeGC and 1.5% MeGC-MMT hydrogels were covered by new
bone at 38 and 69%, respectively, whereas the defects left empty
exhibited a minimal healing 6 weeks post surgery (10%). The
BV/TV and Tb. N. rose up to 46% and 6.2 mm−1 for the 1.5%
MeGC-MMT group, considerably higher compared with that of
the MeGC group (16% and 1.5) or the blank group (7% and 0.9).
The 1.5% MeGC-MMT group resulted in the most effective
bone repair in the absence of any exogeneous growth factor or
stem cells.
The quality of new bone formation was further examined by
histological evaluation with H&E, Masson trichrome staining
(Fig. 9). The defect treated with 1.5% MeGC-MMT nanocompo-
site hydrogel was occupied with newly formed bone, and thick
soft tissue and bone-like tissue connected the edges, 6 weeks post
surgery. The blank and MeGC groups presented very little bone
tissue only on the edges of the defects and very thin soft tissue
connecting the defects. Masson trichrome staining revealed an
osteoid matrix formed on the edge of defects treated with the
1.5% MeGC-MMT nanocomposite hydrogel, whereas defects
without any treatment or treated with the MeGC hydrogel were
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Fig. 3 Assessment of cell cytotoxicity. The viability of encapsulated cells in
photocross-linked MeGC-MMT nanocomposite hydrogels with various
amount of MMT ranging from 0 to 4%. The hydrogels were cultured for
24 h. Error bars indicate standard deviation, *p < 0.05, **p < 0.01, ***p <
0.001, and NS, no significance (ANOVA followed by Tukey’s post hoc test)
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only filled with fibrous soft tissue with minimal bone healing. We
have also performed immunohistochemical staining for the
osteogenic markers Runx2 and OCN (Supplementary Fig. 8).
Strong staining was observed in the 1.5% MeGC-MMT
nanocomposite hydrogel group presenting osteoblastic cells,
while weak immunostaining for Runx2 and OCN was detected
within the fibrous tissue induced with the blank and MeGC
groups. No signs of inflammatory responses were noted in all
treated groups.
Discussion
Injectable formulations of living cells and bioactive molecules using
hydrogels would be an ideal route of administration to the target
area without any surgical incisions. In particular, high porosity and
pore interconnectivity are critical for cell ingrowth and mass
transport in 3D constructs27. However, current technology of pre-
paring such interconnected microporous hydrogels by using sacri-
ficing porogen requires severe porogen removal steps employing
acid or base, high temperature, solvent that may have significant
toxicity to encapsulating cells. This study demonstrated a proof-of-
concept of creating interconnected microporous structure in in situ-
forming hydrogels by exploring intercalation chemistry in polymer
chains with nanoclay to facilitate cell filtration, adhesion, pro-
liferation, and differentiation for tissue engineering27. The positively
charged MeGC polymers were well-mixed with weakly negatively
charged MMT. The delamination of the individual layers of MMT
evenly distributed inside the cured nanocomposite hydrogel,
probably led to the interconnected microporous structure. The
unique structure of smectites contributes to the microstructure
change through interactions between nanoclay and polymer chains
creating interlay-pores and inter-particle spaces. This discovery is of
MeGC MeGC + 1.5% MMT MeGC + 3% MMT
50 µm
Fig. 4 Hematoxyline and eosin (H&E) staining of encapsulated cells in photocross-linked MeGC-MMT nanocomposite hydrogels with various amount of
MMT (0%, 1.5%, 3%). The hydrogels were cultured for 7 days (n= 3), scale bar= 50 μm, arrows indicate the cells
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considerable importance in the development of the next generation
of in situ-forming hydrogels with high porosity, because the process
of tissue formation is a highly orchestrated set of temporal and
spatial events that involve infiltration and proliferation of the stem/
progenitor cells, matrix deposition, and vascularization.
In recent years, our group has developed a series of chitosan-
based injectable hydrogels, which were designed for bone tissue
engineering. For example, Arg–Gly–Asp (RGD) and phospho-
serine (PS)-conjugated MeGC (PS–RGD–MeGC) hydrogel was
synthesized to improve cell adhesion by the RGD motifs and
promote osteogenesis by enhancing cell–matrix interactions and
hydroxyapatite nucleation through PS30. Polysulfonate MeGC
was rationally designed to sequester and stabilize endogenous
bone morphogenic protein-2 (BMP-2), therefore to achieve
osteogenesis without applying its exogenous supraphysiological
dosage31. In addition, the bone-forming sterosomes32, the small
molecular drug, i.e. phenamil, and siRNA knocking down noggin
expression33,34 were embedded in MeGC hydrogels to enhance
bone regeneration. All the efforts were proven to be effective
in vivo in the calvarial defects of mice to a large extent, however,
none of the formulation alone has achieved fully satisfied results
within the experimental time yet, typically 6 weeks. One of the
phenomena in all those injectable chitosan-based hydrogels is
that they all bear a continuous microstructure without any pores
(Figs. 2, 4), which probably limits their osteoconductive cap-
ability. The current MeGC-MMT formulation significantly
promoted bone regeneration without any growth factor, small
molecular drug, or gene.
Chitosan, a naturally occurring polymer, is appealing for
tissue-engineering applications due to its high biocompatibility
and hydrophilicity. MeGC hydrogels can be prepared under mild
conditions with visible blue light. The MeGC hydrogel system
supported proliferation and extracellular matrix deposition of
encapsulated mesenchymal stem cells as well25,26,32,35. MMT
belongs to the smectites with a unique structure and high aspect
ratio, no harm to the environment or cells (Fig. 3) and low cost.
Typically, the mechanical properties of hydrogels restrict their
application on hard tissue engineering, such as bone. The lit-
erature reported that the inclusion of nanoclay in the polymer
matrices significantly improve the mechanical and thermal
properties36–38. Young’s modulus and EWC (Fig. 1b, c) were
analyzed and, with the increment of MMT, the mechanical
properties were remarkably improved. The Young’s modulus
was increased more than six times with the 4% MeGC-MMT
nanocomposite hydrogel compared with that of MeGC hydrogel
(<10 kPa), and it was around 30 kPa for the 1.5% MeGC-MMT
nanocomposite hydrogel.
MMT has been used as a filler in hard scaffolds, such as
chitosan–MMT–hydroxyapatite24, gelatin–MMT–cellulose23 scaf-
folds and silk biomaterials22 for bone tissue formation. To the best
of our knowledge, it is the first report to utilize MMT to create
interconnected microporous structure in chitosan-based in situ-
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forming hydrogel just simply by intercalation chemistry (Supple-
mentary Fig. 4). We confirmed the existence of pores in the wet
state of hydrogel with low-vacuum SEM (Fig. 2) and also with
frozen sections (Fig. 4) to avoid the ambiguity as the evaporation
of water in the hydrogel leading to the formation of pores.
Further in vitro characterization of the combination of
MeGC and MMT showed that the optimal weight of MMT was
1.5% w/v, to exhibit the strongest conductive ability in BMSCs,
confirmed with ALP and mineralization staining and their cor-
responding quantification (Fig. 5), as well as specific gene
expression (Fig. 6). We tempted to culture BMSCs only in the
basal medium in the MeGC-MMT hydrogels, and osteogenic
markers (ALP and Runx2) were upregulated on day 7 (Supple-
mentary Fig. 6), indicating potential osteoinductive ability of this
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composite. Further experiments of ectopic bone formation should
be carried out to confirm this speculation. The most appealing
character of this nanocomposite hydrogel is their ability in vivo to
recruit native cells for de novo bone formation (Fig. 7). Satis-
factory results were obtained in the mouse calvarial defect model
only by applying the material itself in the absence of cells or
growth factors. This feature is of importance for translation to the
clinical application, as cells were not necessary to be harvested
and re-implanted back to the patients or expensive growth fac-
tors, such as BMP-2, to be applied. In addition, we have treated
the mouse calvarial defect with commercially available collagen
sponge39 and demineralized bone matrix (DBX)40 for 6 weeks as
positive controls (Supplementary Fig. 7). The defects treated with
1.5% MeGC-MMT hydrogels, collagen sponge, and DBX were
covered by new bone at 69, 23, and 26%, respectively. The BV/TV
and Tb. N. rose up to 46% and 6.2 mm−1 for the 1.5% MeGC-
MMT group, considerably higher compared with that of the
collagen sponge group (6.4% and 2.7) or the DBX group (13.1%
and 4.3). Compared with the commercially available materials,
our newly developed MeGC-MMT hydrogel presents great
potential for bone healing.
The surface charges and the exchange ability of MMT were
well studied for delivery purpose11. Taking advantage of this,
further development of this chitosan-based hydrogel system
specifically for bone tissue engineering is indispensable. The
combination and optimization of PS–RGD–MeGC or poly-
sulfonate MeGC and MMT hold great promise for bone regen-
eration. The critical defect fully filled with regenerated bone
within experimental time will soon be achieved. The underlying
mechanism should be further studied to elucidate the strong
osteoconductivity of this biomaterial and the type of tissue that
replaces the hydrogel site with time progression needs to be
closely monitored as well in our future work.
Our novel nanocomposite hydrogel system can be utilized not
only as 3D scaffolds for non-load-bearing injury site such as
cranial defects but also synthetic biological carriers for stem cells,
bioactive agents, or currently available tissue grafts for regen-
erative medicine. We did not evaluate mechanical properties of
the regenerated bone in this study, because the calvarial defect is
small and the healing site is not load bearing. However, the
further study of biomechanical properties will be needed in other
fracture models such as large segmental defects. It is possible that
the hydrogel may not possess sufficient mechanical properties in
the load-bearing bone defect sites. A promising alternative is to
combine the hydrogel with solid particles or bone graft materials.
In conclusion, we have demonstrated that with the help of
intercalation chemistry, proportional MMT mixing with MeGC
leads to the formation of interconnected microporous structure,
which can promote native cell infiltration, proliferation, and
in situ differentiation in the absence of any growth factors, small
molecular drugs, or genes. This biocompatible, bioactive, and
injectable nanocomposite material shows great promise being
applied in a wide range of tissue regeneration.
Methods
Materials. Glycol chitosan (GC, ~100 kDa, 072-1581) was purchased from Wako
Chemicals USA, Inc. (Richmond, VA, USA). MMT (682659-500G), glycidyl
methacrylate (GMA, 151238-100G), 1-ethyl-3-(3-dimethylaminopropyl)-carbodii-
mide (EDC, E1769-10G), tween-20 (p1379-500ML), p-nitrophenyl phosphate
(N7653-100ML), β-glycerophosphate (G5422-100G), L-ascorbic acid (A5960-25G),
dexamethasone (D4902-25MG), Nitro Blue Tetrazolium (NBT, N5514-25TAB), 5-
bromo-4-chloro-3-indoxylphosphate (BCIP, B6149-50MG), alizarin red S (A5533),
and ethylenediaminetetraacetic acid (EDTA, EDS-1KG) were supplied by Sigma-
Aldrich (St. Louis, MO, USA). The mouse bone marrow stromal cell line (BMSCs,
D1 ORL UVA [D1], D1 cell, CRL-12424) was obtained from American Type
Culture Collection (ATCC, Manassas, VA, USA). High glucose Dulbecco’s Mod-
ified Eagle’s Medium (DMEM, 11995-065), penicillin/streptomycin (100 U/mL,
15140122) were purchased from Life Technologies (Grand Island, NY, USA), and
fetal bovine serum (FBS, MT35010CV) was supplied by Mediatech Inc. (Manassas,
VA, USA). The live/dead staining solution (L3224) and cDNA transcription kit
(18080-051) were purchased from Invitrogen (Carlsbad, CA, USA). Trizol reagent
(15596018) and RNeasy Mini Plant Kit (74106) were supplied by Qiagen (Valencia,
CA, USA). Pierce BCA Protein Assay Kit was obtained from Thermo Scientific
(23235, Rockford, IL, USA). The nude mice were purchased from Charles River
Laboratories (Wilmington, MA, USA). All solvents and products were used as
received.
Preparation of MeGC and MeGC-MMT nanocomposite hydrogels. In all, 2%
(w/v) GC and GMA were mixed at 1:1 molar ratio of GMA to the amino groups in
GC in Milli-Q water. The solution was adjusted to pH 9.0, and placed on a shaker
at room temperature. After 40 h, pH was readjusted to 7.0, and the solution was
dialyzed with 50 kDa tubes against Milli-Q water for 16 h. After lyophilization and
rehydration with phosphate-buffered saline (PBS), a 4% (w/v) MeGC solution was
obtained. MMT was dispersed in Milli-Q water and yield 100 mgmL−1 stock
dispersion. Various amount of MMT (w/v) was mixed with 4% (w/v) MeGC
solution, and the hydrogels were cured under visible blue light with riboflavin as
the photoinitiator (final concentration 6 µM). The final concentration of MeGC is
2% (w/v) with various amount of MMT.
Characterization of MeGC-MMT nanocomposite hydrogels. A 400 μL of
hydrogel mixture was cured for 80 s in a 48-well plate, and compressive modulus
was measured using a flat-ended indenter (1.6 mm in diameter) on an Instron
Electro-Mechanical Testing Machins (Instron, Model 5564, Norwood, MA, USA).
The Young’s modulus was determined from the slope of linear portion of the
obtained stress-strain curve using a Poissons’ ratio of 0.2525,41,42.
Hydrogels were equilibrated in PBS for 24 h and lyophilized for 16 h to obtain
dry gels. EWC was calculated using the following equation
EWC ¼ Mw Md
Mw
; ð1Þ
where Mw and Md refer to the weight of wet and dry hydrogels, respectively.
The degradation of hydrogels was carried out for 42 days. Hydrogels were
incubated at 37 °C in cell growth medium (DMEM, 10% FBS, and 1% P/S), which
was replaced every 7 days. At a pre-set time, hydrogels were lyophilized for weight
measurement. The present residual weight of hydrogels was calculated using the
following equation
Residual dry gel weight% ¼ Mt
M0
´ 100%; ð2Þ
where M0 and Mt refer to the weight of hydrogels at time 0 (hydrogels did not
undergo degradation) and t, respectively.
Hydrogels were imaged in low vacuum using scanning electron microscopy
with X-ray microanalysis (SEM/EDS, FEI Nova NanoSEM 230, Hillsboro, OR,
USA) to observe the microstructure and chemical compositions. For Transmission
Electron Microscope (TEM) analysis, hydrogels were embedded in sucrose-PVP
and mounted on Cu EM grid after sectioning with glass 45o knife with 100 -nm
thickness (Leica UC6/F6 −100 oC), then imaged with JEM1200EX. The
thermogravimetric analysis (TGA) was performed with the lyophilized hydrogels
from 50 oC to 600 oC at 30 oC min−1 speed. The Powder X-ray Diffraction (XRD,
Bruker Corporation, Germany) pattern was collected from 2 to 10o (2θ range) with
a diffractometer using Ni-filtered CuKα X-ray radiation (λ= 1.5418 Å).
3D cell culture in MeGC-MMT nanocomposite hydrogels. BMSCs at a density
of 2 × 106 cells mL−1 were mixed in MeGC-MMT dispersion. The hydrogel was
cured by exposing 40 μL of the suspension to visible blue light (400–500 nm,
500–600 mW cm−2, Bisco Inc., Schaumburg, IL) in the presence of riboflavin as a
photoinitiator, (final concentration 6 µM). The resulting hydrogels were incubated
in 1 mL of media accordingly.
Cytotoxicity. Cytotoxicity of MMT in nanocomposite hydrogels was evaluated
using alamar blue assay and live/dead staining (Invitrogen, Carlsbad, CA).
Hydrogels with encapsulated BMSCs and MMT in various concentrations were
incubated at 37 oC and 5% CO2 in fresh growth medium. Then the medium was
replaced with 10% (v/v) alamar blue solution in growth medium at a pre-
determined time. After a 3-h incubation, the fluorescence intensity (F) of alamar
blue was measured at 585 nm with an excitation wavelength of 570 nm. For the
blank group, the 10% (v/v) alamar blue solution was added in an empty well and
incubated together with other samples. The relative cell viability (%) was calculated
using the following equation
Relative cell viability ¼ Fs  Fb
Fc  Fb
´ 100%; ð3Þ
where Fs, Fc, and Fb refer to the fluorescence intensity of the sample after incu-
bation for 24 h, intensity of the corresponding sample without treatment, and the
blank, respectively.
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ALP and alizarin red S staining and quantification. Gels were incubated in
osteogenic media (growth medium was supplemented with 10 mM β-glyceropho-
sphate, 50 μg mL−1 L-ascorbic acid, and 100 nM dexamethasone). At a pre-
determined time, gels were fixed in 10% formalin for 20 min, rinsed with PBS, and
incubated in a solution consisting of NBT and BCIP stock solutions in an ALP
buffer (100 mM Tris, 50 mM MgCl2, 100 mM NaCl, pH 8.5) for 2 h, at room
temperature. The stained samples were observed with an Olympus SZX16 Ste-
reomicroscope (Olympus, Tokyo, Japan). ALP expression appeared in blue. For the
ALP activity assay, gels were rinsed with PBS, incubated in a lysis buffer (0.1%
Tween-20 in PBS) at 4 °C for 5 min. ALP activity was determined colorimetrically
using p-nitrophenyl phosphate as a substrate and measured at 405 nm. The ALP
activity was normalized to total DNA contents measured with the picogreen assay
(Thermo Scientific, Rockford, IL).
Gels were fixed in 10% formalin for 20 min, rinsed with PBS, and incubated in
2% alizarin red S solution for 5 min at room temperature. Then, the gels were
washed with PBS under gentle shaking for 16 h, and the PBS was changed at least
three times. The stained samples were observed with the Olympus SZX16
Stereomicroscope. Calcium deposition appeared in red. The semi quantification of
alizarin red S staining was carried out with acetic acid extraction and neutralization
with ammonium hydroxide, followed by a colorimetric detection at 405 nm.
RNA extraction and quantitative real-time PCR. The total RNA was extracted
using Trizol reagent and RNeasy Mini kit. In all, 500 ng of total RNA was reversely
transcribed to cDNA using a cDNA transcription kit (Invitrogen). Quantitative
real-time PCR was performed with a LightCycler 480 PCR (Indianapolis, IN) with
a 20 μL SYBR Green reaction system. PCR amplification was performed for 50
cycles. The expression of housekeeping gene (GAPDH) was employed to normalize
gene expression levels. The primer sequences are listed in Supplementary Table 2.
Calvarial defect model. All animal experiments were performed in accordance
with the guidelines of the Chancellor’s Animal Research Committee at the Uni-
versity of California, Los Angeles. Calvaria of male CD-1 nude mice (8–12 weeks
old) were exposed to a trephine drill under constant irrigation, and 3-mm full-
thickness craniotomy defects were created in the right side of parietal bone with
care to avoid injury to the underlying dura mater. Each defect was syringed with
sterile saline solution to remove bone debris and then implanted with MeGC-MMT
nanocomposite hydrogels through injecting MeGC-MMT sol followed by in situ
curing with visible blue light or left without any treatment. After surgery, all
animals were allowed to recover on a warm sheet and then transferred to the
vivarium for postoperative care. In preparation for the operative treatment, all
animals received analgesia with subcutaneous injections of buprenorphine at a
concentration of 0.1 mg kg−1 for 3 days. To prevent a potential infection, all ani-
mals received drinking water including trimethoprim–sulfamethoxazole for 7 days.
Micro-computerized tomography (μCT) scanning. Six weeks post implantation,
animals were euthanized and calvarial tissues were harvested for analysis. The
extracted calvarial tissues were fixed in 4% formaldehyde at room temperature with
gentle shaking. After 48 h, the fixed samples were rinsed with PBS and imaged
using the high-resolution μCT (SkyScan 1172; SkyScan, Kontich, Belgium) with
57 kVp, 184 μA, 0.5 mm aluminum filtration, and 10 μm resolution. Visualization
and reconstruction of the data were obtained using the OsiriX MD imaging soft-
ware. The new bone surface area was measured using ImageJ software (NIH,
Bethesda, MD), and normalized to the original defect surface area (3 mm in
diameter). Bone volume density (bone volume/tissue volume, BV/TV [%]) and
trabecular number (TN; mm−1) were measured with CTan (Skyscan).
Histological evaluation. MeGC-MMT hydrogels were frozen-sectioned to 5-μm-
thick slides to evaluate the microstructure. The fixed tissues were decalcified in 10%
EDTA solution under gentle shaking for 1 week. The EDTA solution was changed
once at day 3. Decalcified samples were embedded in paraffin, and cut into 5-μm-
thick sections. The tissue sections were deparaffinized and stained with H&E.
Masson trichrome staining was also performed to detect new bone formation. The
blue color, indicative of new or mature bone, was observed using an Olympus IX71
microscope. Additional sections underwent immunohistochemical analysis. The
deparaffinized sections were processed with citric acid for antigen retrieval and
thereafter incubated with the primary antibody osteocalcin (OCN, 1:150 dilution,
Santa Cruz FL-95) and Runx2 (1:150 dilution, Santa Cruz F-2) and were detected
by the HRP/DAB kit (Abcam). The sections were further counterstained with
Mayer’s hematoxylin.
Statistical analysis. Three independent experiments at least, unless otherwise
stated, were performed and data were presented as mean ± standard deviation.
Multiple comparisons were assessed using one-way or two-way analysis of variance
(ANOVA). The analysis of variances followed by Tukey’s post hoc test was
employed in this work and p < 0.05 was considered statistically significant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data are available within the article and Supplementary Information. The
source data underlying Figs. 1B–D, 2, 3, 5B–C, and 66 and Supplementary Figs. 1, 4, 5, 6,
and 7B are provided as a Source Data file. Requests for other materials should be
addressed to the corresponding author.
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